Monopar CFO Buys 1,228 Shares as Insider Buying Surge Signals Management Confidence in Growing Oncology Pipeline
Monopar CFO’s recent share buy shows strong insider confidence amid a 162% YTD gain and rising social buzz—signaling solid long‑term upside for investors.
3 minutes to read
